anti-cd20 antibody therapy in first-line mzl
Published 6 years ago • 372 plays • Length 2:25Download video MP4
Download video MP3
Similar videos
-
2:55
first-line therapy in advanced mzl
-
2:55
first-line therapy in advanced mzl
-
2:09
advanced mzl: first-line treatment considerations
-
2:09
advanced mzl: first-line treatment considerations
-
3:12
using novel therapies in mzl
-
3:23
cd19 and cd20 antibodies in development
-
5:40
appropriately diagnosing and classifying mzl
-
21:17
new anti-cd20 antibodies for cll - are they better than rituximab?
-
2:42
frontline treatment considerations for patients with mzl
-
2:23
second-line therapy in advanced mzl
-
4:11
first-line treatment for mantle cell lymphoma
-
2:23
second-line therapy in advanced mzl
-
4:34
second-line treatment options for patients with mzl
-
2:46
selecting the appropriate first-line therapeutic approach for patients with mzl
-
2:15
ibrutinib as second-line therapy in refractory mzl
-
4:12
case overview: advanced mzl with disease progression
-
4:16
considerations for diagnosing mzl
-
2:00
managing extranodal mzl
-
1:47
current treatment approaches in extranodal mzl & the need to enhance prognostication strategies